Stock Taper
EARNINGS CALL ARCHIVE 4 CALLS ON FILE
INO — Inovio Pharmaceuticals, Inc.
NASDAQ
FULL STOCK PAGE →

Q3 2025 Earnings Call Summary

NOV 10, 2025
REVENUE
$0
EPS
-$0.87 -42.6%
FREE CASH FLOW
-$21.6M -3.8%

No summary has been written for this call yet.